Effect of garlic supplementation pill in dialyisic patient

Evaluation effect of garlic supplementation pill on dialysis adequacy , serum albumin, PTH, calcium, phosphorus, CRP levels and blood lipid profile in patients undergoing chronic hemodialysis in Khorshid and amin hospital (Esfahan)2020-2021

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210825052286N1

Enrollment

Registered

2021-10-17

Start date

2021-11-22

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease. Chronic kidney disease (CKD)

Interventions

Intervention 1: Intervention group: Garlic pill made by Gol Daroo Pharmaceutical Company, which is odorless and contains 500 mg of garlic t and 2 mg of allicin, two pills daily after lunch. Intervent

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Chronic kidney Patients that undergoing hemodialysis for at least three months

Exclusion criteria

Exclusion criteria: Patients receiving warfarin, clopidogrel Being pregnant

Design outcomes

Primary

Measure	Time frame
Serum albumin. Timepoint: before intervention and 8 weeks after intervention starts. Method of measurement: Blood sampling for serum albumin.;Serum PTH(Para Thyroid Hormone). Timepoint: Before intervention and 8 weeks after intervention starts. Method of measurement: blood sampling for serum PTH.;Serum calcium. Timepoint: Before intervention and 8 weeks after intervention starts. Method of measurement: Blood sampling for serum calcium.;Serum phosphorus. Timepoint: Before intervention and 8 weeks after intervention starts. Method of measurement: Blood sampling for serum phosphorus.;Serum CRP(C-Reactive Peptide). Timepoint: Before intervention and 8 weeks after intervention starts. Method of measurement: Blood sampling for serum CRP(C-Reactive Peptide).;Serum total cholesterol. Timepoint: Before intervention and 8 weeks after intervention starts. Method of measurement: Blood sampling for serum total cholesterol.;Serum Low Density Lipoprotein (LDL). Timepoint: Before intervention and 8 weeks after intervention starts. Method of measurement: Blood sampling for serum Low Density Lipoprotein (LDL).;Serum High Density Lipoprotein (HDL). Timepoint: Before intervention and 8 weeks after intervention starts. Method of measurement: Blood sampling for serum High Density Lipoprotein (HDL).;Serum triglyceride. Timepoint: Before intervention and 8 weeks after intervention starts. Method of measurement: Blood sampling for serum triglyceride.	—

Measure

Time frame

Serum albumin. Timepoint: before intervention and 8 weeks after intervention starts. Method of measurement: Blood sampling for serum albumin.;Serum PTH(Para Thyroid Hormone). Timepoint: Before intervention and 8 weeks after intervention starts. Method of measurement: blood sampling for serum PTH.;Serum calcium. Timepoint: Before intervention and 8 weeks after intervention starts. Method of measurement: Blood sampling for serum calcium.;Serum phosphorus. Timepoint: Before intervention and 8 weeks after intervention starts. Method of measurement: Blood sampling for serum phosphorus.;Serum CRP(C-Reactive Peptide). Timepoint: Before intervention and 8 weeks after intervention starts. Method of measurement: Blood sampling for serum CRP(C-Reactive Peptide).;Serum total cholesterol. Timepoint: Before intervention and 8 weeks after intervention starts. Method of measurement: Blood sampling for serum total cholesterol.;Serum Low Density Lipoprotein (LDL). Timepoint: Before intervention and 8 weeks after intervention starts. Method of measurement: Blood sampling for serum Low Density Lipoprotein (LDL).;Serum High Density Lipoprotein (HDL). Timepoint: Before intervention and 8 weeks after intervention starts. Method of measurement: Blood sampling for serum High Density Lipoprotein (HDL).;Serum triglyceride. Timepoint: Before intervention and 8 weeks after intervention starts. Method of measurement: Blood sampling for serum triglyceride.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzaneh Fatahi

Esfahan University of Medical Sciences

drfatahi79@gmail.com+98 31 3625 6177

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026